AAA
KRRO icon

Affinity Asset Advisors’s Korro Bio KRRO Stock Holding History

Affinity Asset Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8M Buy
+706,904
New +$7.78M 0.41% 58

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Affinity Asset Advisors's KRRO Position: Q1 2026 in Review

Affinity Asset Advisors opened a new position in Korro Bio (KRRO) in Q1 2026: 706,904 shares worth $8M. The stake represents 0.41% of the portfolio and ranks #58 among its holdings.

99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Affinity Asset Advisors held 706,904 shares of Korro Bio worth $8M as of Q1 2026.
  • Korro Bio was a new Affinity Asset Advisors position in Q1 2026.
  • Korro Bio made up 0.41% of Affinity Asset Advisors's portfolio in Q1 2026, its #58 holding.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.